Author: Brittney Wheeler

A clinical trial led by School of Medicine researchers has shown that a T cell immunotherapy — in which the patients’ own T cells are genetically modified to attack and kill cancer cells — is effective in treating some patients with rare cancers of the body’s soft tissues. The study focused on the rare cancers synovial sarcoma and myxoid round cell liposarcoma.

The Washington University in St. Louis community is invited to attend a symposium and award ceremony recognizing WashU faculty and community partners for their innovative research and deep engagement with the region.

The Division of Physician-Scientists at Washington University School of Medicine in St. Louis has announced its fifth class of Dean’s Scholars.

John F. DiPersio, MD, PhD, the Virginia E. and Sam J. Golman Professor of Medicine at the School of Medicine, delivered the E. Donnall Thomas Lecture in San Antonio at the Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy and the Center for International Blood and Marrow Transplant Research.

Two innovative pilot projects led by researchers at Washington University School of Medicine have received funding from the Chan Zuckerberg Initiative to address critical challenges in the fields of neurodegeneration and neuroscience.

Renée Shellhaas, MD, the David T. Blasingame Professor of Neurology at Washington University School of Medicine in St. Louis, has been awarded the Child Neurology Society’s 2024 Hower Award.

A new study led by Washington University School of Medicine in St. Louis could help physicians strike the right balance when treating lung cancer patients. Scientists used an artificial intelligence (AI) method to study lung biopsy images and predict whether the cancer will spread to the brain.

Washington University School of Medicine in St. Louis received in 2023 the second highest amount of funding from the National Institutes of Health (NIH) of all medical schools nationwide. This ranking reflects the school’s commitment to cutting-edge research and positions it as a key player in shaping the future of medicine.

Julie K. Schwarz, MD, PhD, a highly regarded radiation oncologist known for her innovative mindset in treating patients and leading research to develop new treatments for deadly gynecologic cancers and heart conditions, has been named a William H. Danforth Washington University Physician Scholar.

Yin Cao, ScD, of Washington University School of Medicine in St. Louis, is leading an international team seeking to understand what is driving the increase in early-onset colorectal cancer globally. To do so, her team has received funding from Cancer Grand Challenges, co-founded by Cancer Research UK and the National Cancer Institute, part of the National Institutes of Health (NIH).